Asthma in the Biologics Era: Should Oral Corticosteroid Therapy Be Relegated to History?
Authors:
- Florence SchleichFSFlorence Schleich
- John J. OppenheimerJOJohn J. Oppenheimer
- Guy BrusselleGBGuy Brusselle
- Liam G. HeaneyLHLiam G. Heaney
- William W. BusseWBWilliam W. Busse
- Njira L. LugogoNLNjira L. Lugogo
- Nicola A. HananiaNHNicola A. Hanania
- Matteo BoniniMBMatteo Bonini
- Marek LommatzschMLMarek Lommatzsch
- Pascal ChanezPCPascal Chanez
- Anna VichiendilokkulAVAnna Vichiendilokkul
- Victoria S. BensonVBVictoria S. Benson
Open Access
- 11 April 2025
- journal article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (7) , 1559-1568
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline plc
This publication has 93 references indexed in Scilit:
- Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthmaAnnals of Allergy, Asthma & Immunology, 2024
- Real-world effectiveness of dupilumab in patients with asthmaAnnals of Allergy, Asthma & Immunology, 2023
- Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatmentAnnals of Allergy, Asthma & Immunology, 2023
- A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of AsthmaAdvances in Therapy, 2023
- Asthma Exacerbations in Severe Asthma: Why Systemic Corticosteroids May not Always Be the Best Treatment OptionCurrent Treatment Options in Allergy, 2023
- A Renewed Charter: Key Principles to Improve Patient Care in Severe AsthmaAdvances in Therapy, 2022
- Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?Chest, 2022
- Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 StudyAnnals of Allergy, Asthma & Immunology, 2022
- A Charter to Improve Patient Care in Severe AsthmaAdvances in Therapy, 2018
- Cost and health care utilization in patients with asthma and high oral corticosteroid useAnnals of Allergy, Asthma & Immunology, 2017